WT1 expression at diagnosis does not predict survival in pediatric aml: A report from the Children's Oncology Group
- 17 July 2009
- journal article
- research article
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 53 (6) , 1136-1139
Abstract
WT1 is a transcription factor that is aberrantly overexpressed in acute and chronic leukemias. Overexpression of WT1 in pediatric acute myeloid leukemia has been reported, but the prognostic significance is unclear because sample sizes in these studies have been relatively small. WT1 expression was measured by quantitative RT‐PCR in samples obtained at diagnosis from 155 pediatric AML patients treated on a cooperative group protocol. Neither overall survival nor event‐free survival was correlated with WT1 expression. Pediatr Blood Cancer 2009;53:1136–1139.Keywords
Funding Information
- Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grant (5T32CA060441-15)
- Children's Cancer Foundation
- NIH (CA120535)
This publication has 24 references indexed in Scilit:
- Mutation of the Wilms’ Tumor 1 Gene Is a Poor Prognostic Factor Associated With Chemotherapy Resistance in Normal Karyotype Acute Myeloid Leukemia: The United Kingdom Medical Research Council Adult Leukaemia Working PartyJournal of Clinical Oncology, 2008
- Wilms’ Tumor 1 Gene Mutations Independently Predict Poor Outcome in Adults With Cytogenetically Normal Acute Myeloid Leukemia: A Cancer and Leukemia Group B StudyJournal of Clinical Oncology, 2008
- Cardiomyopathy in Children With Down Syndrome Treated for Acute Myeloid Leukemia: A Report From the Children's Oncology Group Study POG 9421Journal of Clinical Oncology, 2008
- Prognostic significance of WT1 gene expression in pediatric acute myeloid leukemiaPediatric Blood & Cancer, 2007
- High WT1 Expression After Induction Therapy Predicts High Risk of Relapse and Death in Pediatric Acute Myeloid LeukemiaJournal of Clinical Oncology, 2006
- Wilms' tumor gene 1 (WT1) expression in childhood acute lymphoblastic leukemia: a wide range of WT1 expression levels, its impact on prognosis and minimal residual disease monitoringLeukemia, 2005
- Pediatric Oncology Group (POG) studies of acute myeloid leukemia (AML): a review of four consecutive childhood AML trials conducted between 1981 and 2000Leukemia, 2005
- An isoform of the Wilms' tumor suppressor gene potentiates granulocytic differentiationLeukemia, 2003
- Real-time quantitative PCR detection of WT1 gene expression in children with AML: prognostic significance, correlation with disease status and residual disease detection by flow cytometryLeukemia, 2002
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001